Brilacidin exhibited potent in vitro antiviral activity against SARS-CoV-2
On Nov. 1, 2020, scientists announced that increasing evidence shows that both natural and synthetic antimicrobial peptides (AMPs),…
On Nov. 1, 2020, scientists announced that increasing evidence shows that both natural and synthetic antimicrobial peptides (AMPs),…
On Nov. 1, 2020, the U.S. Department of Defense announced the start of rapid, on-site COVID-19 testing for…
On Oct. 31, 2020, the U.S. Department of Health and Human Services and the U.S. Department of Defense…
On Oct. 31, 2020, the U.S. Department of Health and Human Services (HHS) announced that 389,040 state-of-the-art Abbott…
On Oct. 30, 2020, Hologic announced that it had been awarded a $119 million contract from the U.S….
On Oct. 30, 2020, Humanigen announced that MedStar Washington Hospital Center in Washington, D.C. treated its first COVID-19…
On Oct. 30, 2020 InBios announced that it had received Emergency Use Authorization from the U.S. Food and…
On Oct. 30, 2020, the U.S. Department of Health and Human Services (HHS) and the U.S. Department of…
On Oct. 30, 2020, the University of Oxford announced that Kenya had joined the global efforts in search…
On Oct. 30, 2020, Innovation Pharma and George Mason University jointly announced completion of extensive laboratory testing supporting…
On Oct. 30, 2020, Kaiser Permanente Washington Health Research Institute (KPWHRI) announced enrollment of volunteers in a phase…
On Oct. 30, 2020, the Centers for Disease Control and Prevention (CDC) issued a Framework for Conditional Sailing…
On Oct. 30, 2020, Regeneron announced that ot had received a recommendation from the independent data monitoring committee…
On Oct. 30, 2020, Icosavax announced the launch of the companyメs COVID-19 vaccine program with preclinical data on…
On Oct. 29, 2020, OncoSec Medical announced that the FDA had approved the Investigational New Drug (IND) application…
On Oct. 29, 2020, the National Institutes of Health (NIH) announed that it will begin requiring most of…
On Oct. 29, 2020, Emulate announced that it had entered into a Cooperative Research and Development Agreement (CRADA)…
On Oct. 29, 2020, Mammoth Biosciences announced that it had signed agreements with MilliporeSigma and Hamilton Company targeting…
On Oct. 29, 2020, the University of California, Berkeley (UC Berkeley) announced that it had launched a new…
On Oct. 29, 2020, PerkinElmer announced that the FDA had issued Emergency Use Authorization (EUA) to allow sample…
On Oct. 29, 2020, Humanigen announced that the first patient had been dosed at the Emory University School…
On Oct. 29, 2020, the University of Oxford announced a new pilot scheme to assess the use of…
On Oct. 29, 2020, the Centers for Disease Control and Prevention (CDC) opened its new South America regional…
On Oct. 29, 2020, AquaBounty Technologies announced that it had identified Mayfield, Kentucky as the potential location for…
On Oct. 29, 2020, Takeda Pharmaceutical announced that it would import and distribute 50 million doses of Moderna’s…
On Oct. 28, 2020, Eli Lilly announced an initial agreement with the U.S. government to supply 300,000 vials…
On Oct. 28, 2020, CVS Health announced plans to expand COVID-19 testing services currently offered at select CVS…
On Oct. 28, 2020, researchers at the University of Nebraska Medical Center (UNMC) reported the results of a…
On Oct. 28, 2020, Novartis and Molecular Partners announced an option and license agreement to develop, manufacture and…
On Oct. 28, 2020, researchers at the NIH announced that they had discovered a biological pathway that the…